Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Exempting Generic Drug Makers from Lawsuits
The Supreme Court recently ruled that generic drug makers cannot be sued on the grounds of adverse side effects if their product warning labels are the same as those from the brand-name manufacturers. The court overruled a multimillion dollar jury award to a woman in New Hampshire who was severely disfigured after taking a generic anti-inflammatory. In effect, the Supreme Court said the federal law trumps state law.